Intrasense S.A. (EPA:ALINS)

Market Cap	10.80M -16.0%
Revenue (ttm)	2.65M +13.6%
Net Income	-6.48M
EPS	-0.12
Shares Out	52.66M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,253
Average Volume	65,969
Open	0.1950
Previous Close	0.1940
Day's Range	0.1945 - 0.2070
52-Week Range	0.1900 - 0.4300
Beta	0.25
RSI	37.45
Earnings Date	Mar 11, 2026

About Intrasense

Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, a, oncological imaging platform that automates the identification and measurement of lesions. The company was incorporated in 2004 and is headquartered in Montpellier, France.

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2004
• Employees: 76
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALINS

Financial Performance

In 2024, Intrasense's revenue was 2.25 million, a decrease of -32.04% compared to the previous year's 3.31 million. Losses were -5.66 million, 58.0% more than in 2023.